Labcorp Holdings Inc 2024 SR
The report highlights Labcorp's commitment to improving health and lives through diagnostics and drug development. In 2024, the company achieved a 10% reduction in Scope 1 and 2 emissions toward its 2030 targets and increased renewable energy usage to 23%. Key milestones include the launch of Global Trial Connect to promote clinical trial inclusivity and the distribution of over 200 grants via the Labcorp Charitable Foundation. The company also maintained its CDP B rating and improved its EcoVadis score to 58.
Company: Labcorp Holdings Inc
Sector: Healthcare & social services
Country: United States
Year: 2024
Type: SR
Pages: 60
Back to company
Labcorp Holdings Inc
Corporate Responsibility Report
The report highlights Labcorp's commitment to improving health and lives through diagnostics and drug development. In 2024, the company achieved a 10% reduction in Scope 1 and 2 emissions toward its 2030 targets and increased renewable energy usage to 23%. Key milestones include the launch of Global Trial Connect to promote clinical trial inclusivity and the distribution of over 200 grants via the Labcorp Charitable Foundation. The company also maintained its CDP B rating and improved its EcoVadis score to 58.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Mar 25, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Employees